Stocks CURV Financial statements
Financial statementsTorrid Holdings Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Torrid Holdings Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 1,037 | 984 | 1,297 | 1,288 | 1,152 | 1,104 | 1,000 |
| Cost of revenue | 641 | 643 | 760 | 829 | 746 | 690 | 652 |
| Gross profit | 396 | 341 | 537 | 460 | 406 | 413 | 348 |
| Selling, general and administrative | 253 | 233 | 439 | 298 | 293 | 302 | 269 |
| Operating income | 77 | 56.8 | 45.4 | 102 | 57.1 | 57.2 | 21.4 |
| Interest expense | 16.5 | 21.3 | 29.5 | 29.7 | 39.2 | ||
| Other non-operating income | -0.21 | 0.09 | 0.03 | 0.88 | |||
| Pre-tax income | 60.7 | 35.5 | 15.8 | 71.7 | 18 | 21.6 | -9.56 |
| Income tax | 18.8 | 11 | 45.8 | 21.5 | 6.42 | 5.29 | -2.53 |
| Net income | 41.9 | 24.5 | -29.9 | 50.2 | 11.6 | 16.3 | -7.03 |
| EBITDA | 108 | 91.4 | 82.1 | 139 | 95.2 | 94.4 | 57.5 |
| EPS, basic | 0.38 | 0.22 | -0.27 | 0.48 | 0.11 | 0.16 | -0.07 |
| EPS, diluted | 0.38 | 0.22 | -0.27 | 0.48 | 0.11 | 0.15 | -0.07 |
| Shares, basic (weighted) | 110 | 110 | 110 | 104 | 104 | 105 | 101 |
| Shares, diluted (weighted) | 110 | 110 | 110 | 104 | 104 | 106 | 101 |
Balance sheet
| FY2021 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 29 | 123 | 29 | 13.6 | 11.7 | 48.5 | 20 |
| Inventory | 106 | 171 | 180 | 142 | 148 | 136 | |
| Other current assets | 12.7 | 14.7 | 20.1 | 22.2 | 24.5 | 24.6 | |
| Total current assets | 242 | 221 | 216 | 179 | 226 | 193 | |
| Property, plant and equipment | 143 | 128 | 114 | 104 | 77.7 | 51.6 | |
| Lease right-of-use assets | 245 | 210 | 177 | 162 | 141 | 108 | |
| Intangible assets | 8.4 | 8.4 | 8.4 | 8.4 | 8.4 | 8.4 | |
| Total assets | 648 | 579 | 527 | 477 | 488 | 400 | |
| Accounts payable | 70.9 | 77.4 | 76.2 | 46.2 | 72.4 | 56.8 | |
| Accrued liabilities | 25.6 | 31.2 | 20.2 | 13.8 | 25.3 | 14.3 | |
| Short-term debt | 11.5 | 20.5 | 16.1 | 16.1 | 16.1 | 16.1 | |
| Total current liabilities | 261 | 297 | 267 | 232 | 263 | 249 | |
| Long-term debt | 193 | 321 | 305 | 289 | 272 | 256 | |
| Lease liabilities | 246 | 207 | 172 | 156 | 134 | 101 | |
| Other non-current liabilities | 0 | 0.29 | 0 | 0.27 | 0.2 | ||
| Total liabilities | 711 | 837 | 757 | 689 | 680 | 614 | |
| Total debt | 205 | 341 | 321 | 305 | 289 | 272 | |
| Paid-in capital | 10.3 | 118 | 128 | 135 | 140 | 145 | |
| Retained earnings | -74.6 | -378 | -359 | -348 | -331 | -338 | |
| Treasury stock | 0 | -20.3 | |||||
| Other comprehensive income | -0.01 | 0.08 | -0.26 | -0.31 | -0.9 | -0.61 | |
| Shareholders' equity | -95.5 | -63.2 | -258 | -230 | -212 | -191 | -213 |
| Total equity | -95.5 | -63.2 | -258 | -230 | -212 | -191 | -213 |
| Total liabilities and equity | 648 | 579 | 527 | 477 | 488 | 400 | |
| Shares outstanding | 110 | 108 | 104 | 104 | 105 | 99.3 |
Cash flow statement
| FY2021 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | 41.9 | 24.5 | -29.9 | 50.2 | 11.6 | 16.3 | -7.03 |
| Depreciation and amortization | 31.2 | 34.6 | 36.7 | 37.6 | 38 | 37.2 | 36.1 |
| Stock-based compensation | 12 | 7.79 | 160 | 9.98 | 8.04 | 7.63 | 5.21 |
| Deferred income tax | -4.69 | -1.06 | 1.31 | 1.85 | -5.67 | -7.92 | -2.45 |
| Change in inventory | -17.4 | 7.88 | -65.7 | -12 | 33.2 | -7.62 | 9.03 |
| Change in payables | 5.31 | 37.8 | 5.64 | -1.24 | -30.3 | 27 | -15.4 |
| Cash from operations | 99.1 | 152 | 121 | 53.3 | 42.8 | 77.4 | -13 |
| Capital expenditures | -26.3 | -11.6 | -17.6 | -23.4 | -26 | -14.4 | -8.85 |
| Cash from investing | -56.1 | -11.6 | -17.6 | -23.4 | -26 | -14.4 | -8.85 |
| Share buybacks | 0 | 0 | -23.4 | -31.7 | 0 | 0 | -20.1 |
| Cash from financing | -23.3 | -45.9 | -198 | -45.1 | -18.5 | -24.5 | -7.18 |
| Exchange rate effect | -0.01 | -0.11 | 0.21 | -0.18 | -0.05 | -1.71 | 0.56 |
| Net change in cash | 19.6 | 94.2 | -93.9 | -15.4 | -1.8 | 36.8 | -28.5 |
| Free cash flow | 72.8 | 140 | 104 | 29.9 | 16.8 | 63 | -21.9 |
| Interest paid | 10.6 | 21.3 | 24.1 | 29.6 | 34.2 | 35.1 | 32.4 |
| Income taxes paid | 22.4 | 3.92 | 58.1 | 15.6 | 11.2 | 17.8 | 8.93 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 34.7% | Gross profit / revenue. |
| Operating margin | 1.9% | Operating income / revenue. |
| EBITDA margin | 4.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -1.3% | Pre-tax income / revenue. |
| Net margin | -0.9% | Net income / revenue. |
| FCF margin | -1.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -0.1% | Cash from operations / revenue. |
| Return on assets (ROA) | -2.4% | Net income / average total assets. |
| Return on invested capital (ROIC) | 39.6% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 26.8% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.7% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.3% | Capital expenditures / revenue. |
| D&A / revenue | 3.0% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -9.4% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -8.1% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 0.3% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -15.8% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -8.9% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 0.4% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -62.6% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -40.5% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | -17.7% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -39.1% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -25.5% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | -8.8% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | -143.1% | Net income vs the same period a year earlier. Only from a positive base. |
| EPS growth, 1y | -146.7% | EPS vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -116.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | -134.7% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Total assets growth, 1y | -18.0% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -8.8% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -9.2% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -4.0% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -1.0% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -1.6% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.79x | Current assets / current liabilities. |
| Quick ratio | 0.09x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.09x | (Cash + short-term investments) / current liabilities. |
| Debt / assets | 71.2% | Total debt / total assets. |
| Liabilities / assets | 155.4% | Total liabilities / total assets. |
| Net debt | $242.3M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 5.23x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Working capital | -$48.3M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 2.3% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$214.2M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 2.55x | Revenue / average total assets. |
| Fixed asset turnover | 20.2x | Revenue / average property, plant and equipment. |
| Inventory turnover | 4.93x | Cost of revenue / average inventory. |
| Days inventory | 74 days | 365 x average inventory / cost of revenue. |
| Days payables | 34 days | 365 x average accounts payable / cost of revenue. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.09 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $9.47 | Revenue / diluted weighted shares. |
| FCF per share | -$0.13 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$0.01 | Cash from operations / diluted weighted shares. |
| Book value per share | -$2.06 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$2.15 | Tangible book value / shares outstanding. |
| Cash per share | $0.22 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $233.9M | Share price x shares outstanding. |
| Enterprise value | $476.2M | Market cap + total debt - cash - short-term investments. |
| P/S | 0.25x | Market cap / revenue. |
| EV/Sales | 0.50x | Enterprise value / revenue. |
| EV/EBIT | 26.0x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 10.3x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -5.7% | Free cash flow / market cap. |
| Earnings yield | -3.8% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 0.1% | (Dividends paid + share buybacks) / market cap. |
What was Torrid Holdings Inc.'s revenue in fiscal 2025?
Torrid Holdings Inc. reported revenue of $1.00B for fiscal 2025, 9.4% lower than the year before.
Was Torrid Holdings Inc. profitable in fiscal 2025?
No. It reported a net loss of $7.0M.
How much free cash flow did Torrid Holdings Inc. generate in fiscal 2025?
Cash from operations of $13.0M minus capital expenditures of $8.9M left free cash flow of -$21.9M.